Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Jean-Michel Senard »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Jean-Michel Mayer < Jean-Michel Senard < Jean-Pascal Lefaucheur  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000208 (2010) Jean-Louis Montastruc [France] ; Anne Charlotte Danton [France] ; Genevieve Durrieu [France] ; Isabelle Lacroix [France] ; Pascale Olivier [France] ; Agnés Sommet [France] ; Jean-Michel Senard [France]Neuropathy as a potential complication of levodopa use in Parkinson's disease: A Pharmacological and Pharmacovigilance point of view
000382 (2006) Anne Pavy-Le Traon [France] ; Richard L. Hughson [Canada] ; Claire Thalamas [France] ; Monique Galitsky [France] ; Nelly Fabre [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France]Cerebral autoregulation is preserved in multiple system atrophy: A transcranial Doppler study
000389 (2006) Anne Pavy-Le Traon [France] ; Richard L. Hughson [Canada] ; Claire Thalamas [France] ; Monique Galitsky [France] ; Nelly Fabre [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France]Cerebral autoregulation is preserved in multiple system atrophy : A transcranial doppler study
000401 (2005) Atul Pathak [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Jean-Michel Senard [France]Heat‐related morbidity in patients with orthostatic hypotension and primary autonomic failure
000457 (2003) Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Clinical and economic analysis of spa therapy in Parkinson's disease
000458 (2003) Frédéric Courbon [France] ; Christine Brefel-Courbon [France] ; Claire Thalamas [France] ; Marie Jeanne Alibelli [France] ; Isabelle Berry [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France]Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease
000463 (2003) Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Clinical and economic analysis of spa therapy in Parkinson's disease
000508 (2001) Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France]Long‐term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease
000535 (1999) Jean Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France]Treatment of Parkinson's disease should begin with a dopamine agonist
000591 (1997) Nathalie Andreu [France] ; Christine Damase-Michel [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Montastruc [France]A dose‐ranging study of selegiline in patients with Parkinson's disease: Effect on platelet monoamine oxidase activity
000616 (1995) Jean-Louis Montastruc [France] ; Nelly Fabre [France] ; Olivier Blin [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; André Rascol [France]Does fluoxetine aggravate Parkinson's disease? A pilot prospective study
000629 (1994) Rascol [France] ; Nelly Fabre [France] ; Olivier Blin [France] ; Janet Poulik [France] ; Umberto Sabatini [France] ; Jean-Michel Senard [France] ; Michèle Ané [France] ; Jean-Louis Montastruc [France] ; André Rascol [France]Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease

List of associated KwdEn.i

Nombre de
documents
Descripteur
10Humans
7Aged
7Female
7Male
6Human
6Parkinson Disease (drug therapy)
6Parkinson disease
6Parkinson's disease
5Middle Aged
4Drug Therapy, Combination
3Antiparkinson agent
3Bromocriptine (therapeutic use)
3Diseases of the autonomic nervous system
3Dose-Response Relationship, Drug
3Levodopa (adverse effects)
3Levodopa (therapeutic use)
3Prospective Studies
3Treatment
2Adult
2Antiparkinson Agents (administration & dosage)
2Antiparkinson Agents (therapeutic use)
2Bromocriptine
2Chemotherapy
2Complication
2Cross-Over Studies
2Levodopa (administration & dosage)
2Multiple system atrophy
2Nervous system diseases
2Neurologic Examination (drug effects)
2Pilot Projects
2Treatment Outcome
2autonomic failure
2multiple system atrophy
2orthostatic hypotension
13-Iodobenzylguanidine (diagnostic use)
13-Iodobenzylguanidine (pharmacokinetics)
1Activity
1Aged, 80 and over
1Agonist
1Agonists
1Amine oxidase (flavin-containing)
1Antidepressant agent
1Antiparkinson Agents (adverse effects)
1Antiparkinson Agents (pharmacology)
1Autonomic Nervous System Diseases (complications)
1Autonomic Nervous System Diseases (diagnosis)
1Autonomic Nervous System Diseases (epidemiology)
1Autonomic Nervous System Diseases (etiology)
1Autonomic Nervous System Diseases (physiopathology)
1Balneology (economics)
1Balneology (methods)
1Benzothiazoles
1Blood Flow Velocity (physiology)
1Blood Platelets (metabolism)
1Blood Pressure (physiology)
1Bromocriptine (administration & dosage)
1Bromocriptine (adverse effects)
1Bromocriptine (pharmacology)
1Cabergoline
1Cerebrovascular Circulation (physiology)
1Clinical trial
1Cost-Benefit Analysis
1Databases, Factual (statistics & numerical data)
1Denervation
1Differential diagnostic
1Disability Evaluation
1Dopamine
1Dopamine Agonists (pharmacology)
1Dopamine Agonists (therapeutic use)
1Dopamine receptor
1Doppler ultrasound study
1Dose activity relation
1Double-Blind Method
1Dyskinesia, Drug-Induced (drug therapy)
1Early
1Early treatment of Parkinson's disease
1Economic analysis
1Effective dose
1Encephalon
1Ergolines (pharmacology)
1Ergolines (therapeutic use)
1Ergot derivatives
1Fluoxetine (administration & dosage)
1Fluoxetine (adverse effects)
1Follow-Up Studies
1France (epidemiology)
1Ganglia, Sympathetic (metabolism)
1Ganglia, Sympathetic (physiopathology)
1Ganglia, Sympathetic (radionuclide imaging)
1Health Care Costs
1Health Resorts
1Heart
1Heart (physiopathology)
1Heart (radionuclide imaging)
1Heart Rate (physiology)
1Heat Exhaustion (complications)
1Heat Exhaustion (epidemiology)
1Homeostasis (physiology)
1Hypotension, Orthostatic (epidemiology)
1Indoles (pharmacology)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Jean-Michel Senard" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Jean-Michel Senard" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Jean-Michel Senard
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024